Search Results 21-30 of 44840 for Two-phase

  1. Delayed sleep phase - Symptoms and causes - Mayo Clinic

    People with delayed sleep phase have sleep patterns that occur two or more hours later than usual patterns. They go to sleep later and wake later. This ...

  2. A Phase 2, Multicenter, Randomized, Open-label Study Of MEDI-551 In Adults With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Clinical Trials · A Phase 2, Multicenter, Randomized, Open-label Study Of MEDI-551 In Adults With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL).

  3. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study ACT16970 consists of 2 parts (A and B) as follows: Part A is a 24 week, double blind, placebo controlled part, preceded by a screening period of up to 4 ...

  4. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

    About this study. This is an adaptive clinical trial that includes a dose escalation phase followed by a randomized controlled Phase 3 trial.

  5. Phase 1/2 Study Of ABO-101 In Primary Hyperoxaluria Type 1 - Mayo Clinic

    A gene editing medication is one that changes a targeted gene forever. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

  6. Open-label, Multi-center, Phase 1b/2 Clinical Trial To Evaluate The Safety And Efficacy Of Autologous CAR-BCMA T-cells (CT053) In Patients

    Clinical Trials · Open-label, Multi-center, Phase 1b/2 Clinical Trial To Evaluate The Safety And Efficacy Of Autologous CAR-BCMA T-cells (CT053) In Patients.

  7. Phase 2/3 Study Of KPL-387 In Recurrent Pericarditis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. A Phase 2, Multicenter, Randomized Study Of AP26113 - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of two different dosing regimens of AP26113 in patients with anaplastic lymphoma kinase (ALK)- ...

  9. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS · More about research at Mayo Clinic.

  10. Phase 2/3 Study Of Efficacy And Safety Of THRV-1268 In Long QT Syndrome Type 2 (LQTS 2) - Mayo Clinic

    The purpose of this study is to evaluate the effect of oral THRV-1268 on QTcF interval by AUC method in participants with LQTS 2. Participation eligibility.